GlassScriptPhysician profile
David S Diamant
NPI 1639153349
$2,231.55
in general payments reported to CMS, 2019-2025
14 companies · $99.39 in 2025
The $99.39 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184 · 2020: $28.20 · 2021: $316 · 2022: $177 · 2023: $1,344 · 2024: $82.80 · 2025: $99.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $841 · Food and Beverage: $685.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $841.36 |
| Food and Beverage | $685.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $1,335.91 | 2020-2023 | Intracept |
| Boston Scientific Corporation | $292.61 | 2019-2025 | Intracept, General - Pain Management |
| Abbvie INC. | $271.88 | 2021-2024 | Qulipta |
| Spr Therapeutics, INC | $65.00 | 2023 | Sprint Pns System |
| Aesculap, INC. | $56.21 | 2023 | M.Blue |
| Allergan, INC. | $55.25 | 2019-2020 | |
| Medtronic, INC. | $45.01 | 2021-2023 | Intellis Adaptivestim |
| Nevro Corp. | $19.13 | 2021 | |
| Novo Nordisk INC | $18.88 | 2025 | Ozempic, Tresiba, Rybelsus |
| Pacira Pharmaceuticals Incorporated | $16.41 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $16.06 | 2021 | |
| Surgalign Spine Technologies, INC. | $15.15 | 2021 | |
| Abbott Laboratories | $14.63 | 2022 | |
| Mml US, INC. | $9.42 | 2025 | Reactiv8 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Diamant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.